Histone acetyltransferases CBP/p300 in tumorigenesis and CBP/p300 inhibitors as promising novel anticancer agents

Chen, QJ; Yang, BH; Liu, XC; Zhang, XD; Zhang, LR; Liu, T

Zhang, XD (通讯作者)，Univ Newcastle, Sch Med & Publ Hlth, Prior Res Ctr Canc Res, Newcastle, NSW 2308, Australia.;Zhang, XD; Liu, T (通讯作者)，Zhengzhou Univ, Acad Med Sci, Henan Prov Peoples Hosp, Translat Res Inst, Zhengzhou, Peoples R China.;Zhang, LR (通讯作者)，Zhengzhou Univ, Sch Basic Med Sci, Dept Pharmacol, Zhengzhou, Peoples R China.;Liu, T (通讯作者)，Childrens Canc Inst Australia, Sydney, NSW 2031, Australia.;Liu, T (通讯作者)，Univ New South Wales, Sch Womens & Childrens Hlth, Sydney, NSW, Australia.

THERANOSTICS, 2022; 12 (11): 4935

Abstract

The histone acetyltransferases CBP and p300, often referred to as CBP/p300 due to their sequence homology and functional overlap and co-operation, are......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索